In the United States,<unk>  can be obtained either as part of the combination pills Stribild or Genvoya, or as the single pill formulation Vitekta. Vitekta is FDA approved to be used for the treatment of HIV-1 infection in adults who have previous treatment experience with antiretroviral therapy. It must be used in combination with a protease inhibitor that is coadministered with ritonavir as well as additional antiretroviral drug(s).
Elvitegravir
Saquinavir
Dolutegravir
Entecavir
Fosamprenavir
Maribavir
Coronavir
Remdesivir